On April 16, 2025, the Cabinet of Ministers of Ukraine published its Resolution #439 (Resolution), approving the following:
- Procedure for Price Referencing of Medicinal Products;
- Procedure for Price Declaration of Medicinal Products in the National Price Catalogue;
- Procedure for National Price Catalogue Creation & Management.
AmCham member companies’ experts participated in the development of this Resolution. The AmCham’s proposals were taken into account, in particular:
- Price referencing does not apply to original (innovative) medicinal products;
- Price declaration does not apply to medicines procured under managed entry agreements and included in the reimbursement program;
- Reference price calculations consider the package size of medicinal products.
We are grateful to the Office of the President of Ukraine and the Government, in particular the Ministry of Health of Ukraine, for maintaining an ongoing dialogue with the business community amid at the implementation of new pharmaceutical market regulations.
